Health Canada is advising consumers not to use the sleep supplement product Optimum Health Care Sleep Easy, because it contains the undeclared drug clonazepam, which can be habit forming when used for as little as a few months. Consumers who may still have this product in their homes are advised to consult with a health care professional before they stop taking the pills, because of the risk of serious withdrawal symptoms.

Health Canada is warning Canadians not to use Neem Active Toothpaste with Calcium, manufactured by Calcutta Chemical Co. Ltd. in India and found on the Canadian market, because it has been found to contain unacceptable levels of diethylene glycol (DEG).

Health Canada is warning consumers not to use Zencore Tabs, a product advertised as a dietary supplement for sexual enhancement, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil. Tadalafil is a prescription medication indicated for the treatment of erectile dysfunction and should only be used under the supervision of a health professional.

Health Canada is advising consumers not to use Liviro3, a natural health product marketed for sexual enhancement, due to concerns about possible side-effects. The product is not authorized for sale in Canada and has not been found in the Canadian marketplace, but is for sale on the Internet, and may have been brought into the country by travellers.

نشرت بعض وسائل الإعلام خبر اكتشاف باحث يمني فوائد احد انواع نبتة الصبار كعلاج طبيعي لمرض السكري . و توصل الباحث بحسب الدراسة إلى أن الصبار يخفض سكر الدم الغير معتمد على الأنسولين في الأرانب, و بإمكان المرضى المصابين بهذا النوع من سكر الدم الاعتماد على هذا النبات بتناوله مثل أي غذاء آخر.

Health Canada is advising Canadians not to use the unauthorized smoking cessation product Resolve™, because of the potential health risk to consumers.

The product contains an unacceptable amount of an ingredient labelled as "CESTEMENOL-350." Consuming excessive amounts of this ingredient might result in damage to the kidney, liver or red blood cells.

Atherosclerotic peripheral arterial disease is associated with an increased risk of myocardial infarction, stroke, and death from cardiovascular causes. Antiplatelet drugs reduce this risk, but the role of oral anticoagulant agents in the prevention of cardiovascular complications in patients with peripheral arterial disease is unclear.

The U.S. Food and Drug Administration is warning consumers in USA not to buy or eat three red yeast rice products promoted and sold on Web sites. The products may contain an unauthorized drug that could be harmful to health. The products are promoted as dietary supplements for treating high cholesterol.

The Medicines and Healthcare products Regulatory Agency (MHRA), the British equivalent of the Saudi Food and Drug Authority (SFDA), announced that reports have been received of serious adverse drug reactions, including deaths, associated with the use of botulinum toxin products. Botox is the only brand name product registered by the Ministry of Health in Saudi Arabia.

The American Food and Drug Administration (FDA), the U.S. equivalent to the Saudi Food & Drug Authority(SFDA), that the manufacturers of the drugs rosiglitazone (Avandia) and pioglitazone (Actos) will revise the prescribing information for these drugs to include stronger warnings about the risk of congestive heart failure when these drug are used to treat type-2 diabetes.